No Data
No Data
Ardent Health Partners, Inc. Just Beat EPS By 33%: Here's What Analysts Think Will Happen Next
Morgan Stanley Maintains Ardent Health Partners(ARDT.US) With Buy Rating, Maintains Target Price $22
Ardent Health Partners Reports Strong 2024 Financial Results
Ardent Health Partners | 10-K: Annual report
A Glimpse Into The Expert Outlook On Ardent Health Partners Through 4 Analysts
Ardent Health Partners Shares Are Trading Higher After the Company Reported Better-than-expected Q4 Financial Results.